Albaconazole

Clinical data
ATC code	none
Identifiers
IUPAC name 7-Chloro-3-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]quinazolin-4-one
CAS Number	187949-02-6 Y
PubChem CID	208952
ChemSpider	181045 Y
UNII	YDW24Y8IAB
KEGG	D09702 Y
ChEMBL	ChEMBL298817 Y
CompTox Dashboard (EPA)	DTXSID3058244
ECHA InfoCard	100.170.829
Chemical and physical data
Formula	C20H16ClF2N5O2
Molar mass	431.83 g·mol−1
3D model (JSmol)	Interactive image
SMILES Fc1ccc(c(F)c1)[C@](O)([C@H](N3\C=N/c2cc(Cl)ccc2C3=O)C)Cn4ncnc4
InChI InChI=1S/C20H16ClF2N5O2/c1-12(28-11-25-18-6-13(21)2-4-15(18)19(28)29)20(30,8-27-10-24-9-26-27)16-5-3-14(22)7-17(16)23/h2-7,9-12,30H,8H2,1H3/t12-,20-/m1/s1 Y Key:UHIXWHUVLCAJQL-MPBGBICISA-N Y
(verify)

Albaconazole (development code UR-9825) is an experimental triazole antifungal.^[1] It has potential broad-spectrum activity. The drug blocks a number of CYP450 liver enzymes.^{[citation needed]}

It has also been studied as an antiprotozoal agent.^[2]